Equity Offerings
Provided by: Set Up E-mail Alerts For Equity Offerings » RSS Feed For Equity Offerings »
Apricus Biosciences, Inc. (Nasdaq: APRI) announced that it has priced an underwritten public offering of an aggregate of 6,000,000 shares of common stock at a price to the public of $2.85 per share, and warrants to purchase up to an aggregate of 3,000,000 shares of common stock for gross offering proceeds of $17,100,000. The shares of common stock and warrants are immediately separable and will be issued separately. The warrants are exercisable immediately upon issuance, have a five-year term and an exercise price of $3.40 per share. The warrants will be certificated, and will be delivered to the investors by physical delivery following the closing. There is no established public trading market for the warrants and we do not expect a market to develop. Certain officers and directors of the Company have also participated in the offering and will be purchasing the offered securities from the underwriters.
In addition, Apricus Bio has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock and warrants to purchase up to an additional 450,000 shares of common stock to cover over-allotments, if any. The net offering proceeds to Apricus Bio from this offering are expected to be approximately $15.8 million, after deducting underwriting discounts and commissions and other estimated offering expenses, but excluding the exercise of any warrants and any exercise of the underwriters' over-allotment option. The offering is expected to close on or about May 29, 2013, subject to customary closing conditions.
Lazard Capital Markets LLC is acting as sole book-running manager for the offering and Roth Capital Partners, LLC and Cantor Fitzgerald & Co. are acting as co-managers for the offering.
Chemical Financial Corp (Nasdaq: CHFC) filed a registration with the U.S. SEC to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Debt Securities, Depositary Shares, Warrants, Purchase Contracts, Units, or any combination thereof.
Bloomin' Brands, Inc. (the "Company") (Nasdaq: BLMN) announced the pricing of a secondary public offering of 19,000,000 shares of the Company's common stock at a price of $21.50 per share. All of the shares are being offered by certain stockholders of the Company. The offering is expected to close on May 29, 2013, subject to the satisfaction of customary closing conditions. In addition, the underwriters have a 30-day option to purchase up to an additional 2,850,000 shares of common stock from certain selling stockholders.
The offering is being made through an underwriting group led by BofA Merrill Lynch, Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, Deutsche Bank Securities Inc., and Goldman, Sachs & Co. who are acting as joint book-running managers. Jefferies LLC is acting as co-lead manager of the offering. William Blair & Company, L.L.C., Raymond James & Associates, Inc, Wells Fargo Securities, LLC, and The Williams Capital Group, L.P. are acting as co-managers of the offering.
Blackstone Mortgage Trust (NYSE: BXMT) announced the pricing of an underwritten public offering of 22,500,000 shares of its class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission at a public offering price of $25.50 per share. The offering was upsized from 16,000,000 shares to 22,500,000 shares. The offering is expected to close on May 29, 2013 and is subject to customary closing conditions. The offering will generate gross proceeds of approximately $573.8 million, or $659.8 million if the underwriters exercise their option to purchase additional shares in full.
The price is up from 16 million shares originally offered.
The Company intends to use the proceeds from the offering to originate and acquire an initial portfolio of senior mortgage loans and pari passu participations in existing senior mortgage loans, to originate and acquire additional commercial real estate loans in the United States and Europe, and for working capital and general corporate purposes.
Citigroup, BofA Merrill Lynch, J.P. Morgan, Deutsche Bank Securities, Wells Fargo Securities and UBS Investment Bank are acting as joint book-running managers for the offering. Blackstone Capital Markets, Keefe, Bruyette & Woods A Stifel Company, Evercore Partners and JMP Securities are acting as co-managers. The underwriters have been granted a 30-day option by the Company to purchase up to an additional 3,375,000 shares at the public offering price, less the underwriting discounts and commissions.
Apricus Biosciences, Inc. (Nasdaq: APRI) is trading down 18 percent after-hours Wednesday after the company announced that it intends to offer shares of common stock and warrants in an underwritten public offering. The Company also expects to grant the underwriters a 30-day option to purchase additional shares of common stock and warrants to cover over-allotments, if any.
Lazard Capital Markets LLC is acting as sole book-running manager for the offering.
More Equity Offerings
View Older Stories-
Baltic Trading (BALT) to Sell 5.58M Common at $3.60/Share
-
PGT (PGTI) Secondary Offering Size Increased, Priced at $7.75/Share
-
NPS Pharmaceuticals (NPSP) Prices 6M Common Stock Offering
-
Sensata (ST) Announces 12.5M Common Share Secondary Offering
-
CVR Partners (UAN) Announces 12M Common Secondary Sale
-
M/A-COM Technology (MTSI) Files 9.24M Common Shelf for Shareholders
-
Pike Electric (PIKE) Closes Secondary Offering, Completes Stock Repurchase
-
Baltic Trading (BALT) Announces Stock Offering
-
First Potomac Realty (FPO) Prices Larger 6.5M Common Stock Offering
-
Cimatron (CIMT) Secondary Offering Priced at $6.25/Share
-
TCP Capital (TCPC) Prices Upsized 4.5M Common Stock Offering
-
Arrowhead Research (ARWR) Files 19.7M Common Shelf for Shareholders
-
QVT Financial Purchase $20M of Convertible Debt Issued by VIVUS (VVUS)
-
NPS Pharma (NPSP) Announces 6M Common Stock Offering
-
Cimatron (CIMT) Announces Common Secondary Offering
-
Oaktree Capital (OAK) Announces 6M Class A Common Units Offering
-
Laclede (LG) Announces 8.7M Common Stock Offering
-
Wesco Aircraft (WAIR) Commences 15M Common Stock Offering for Shareholder
-
First Potomac (FPO) Announces 6M Common Share Offering
-
TCP Capital (TCPC) Announces 4M Common Stock Offering
-
Ironwood Pharm (IRWD) Announces 10.5M Common Offering
-
Evolution Petroleum (EPM) Files $500M Mixed Shelf
-
National Bank of Greece SA (NBG) to Sell 2.27B Shares, 10-for-1 Reverse Split
-
Preferred Apartment (APTS) Files $200M Mixed Shelf
-
Combimatrix (CBMX) Files 1.06M Common Shelf for Shareholders
-
Saul Centers (BFS) Files 4.93M Common Shelf for Holders
-
Ubiquiti Networks (UBNT) Files 7.7M Common Shelf for Shareholders
-
PLX Technology (PLXT) Files $30M Common, Depositary Shelf
-
BioLineRx (BLRX) Enters $20M ATM Offering w/ Stifel
-
Lucas Energy (LEI) Files $10M Mixed Shelf
-
Tesla (TSLA) convertible note sale raised from $525 million to $600 million - DJ
-
Triple-S (GTS) Prices 5.4M Common Secondary Offering
-
MagneGas (MNGA) Files $20M Mixed Shelf
-
Calumet Specialty Products (CLMT) Files $300M Common, Debt Shelf
-
Tesla (TSLA) Prices 3.39M Common Stock Offering
-
Cyclacel (CYCC) Prices 6.67M Common Stock Offering
-
Cubic (CUB) Prices 2.32M Common Secondary Offering
-
DDR Corp (DDR) Prices Upsized 34M Common Stock Offeing
-
Rose Rock Midstream (RRMS) Files $500M Mixed Shelf; 12.5M Common Units for Holders
-
VIVUS (VVUS) Prices $220M Convertible Debt Offering
-
Ducommun (DCO) Files $500M Mixed Shelf
-
Goldman Comments on Tesla Motors (TSLA) Equity and Convertible Debt Issue
-
DDR Corp. (DDR) Commences 32M Common Share Offering
-
Tesla Motors (TSLA) to Offer 2.7M Common, $450M Convertible Senior Notes
-
Tesla Motors (TSLA) filed an automatic shelf registration
-
Cyclacel Pharmaceuticals (CYCC) Announces Stock Offering
-
Standard Pacific (SPF) Lower after 20M Share Offering Prices at $9.50/Sh
-
Acadia Pharmaceuticals, (ACAD) Prices 8M Share Offering at $12.50/Sh
-
Apollo Investment (AINV) Lower After Announcing 18M Share Common Offering
